A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy (IIM). Participants with the IIM subtypes of dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), or certain other subtypes of polymyositis (PM; including antisynthetase syndrome [ASyS]) will be included in the study. Treatment response will be measured by Total improvement score (TIS).
Inclusion Criteria:
Exclusion Criteria:
Scottsdale, Arizona 85251, United States
Los Angeles, California 90033, United States
Redwood City, California 94063-3132, United States
San Francisco, California 94143-2202, United States
Tampa, Florida 33616, United States
Boston, Massachusetts 02115-6110, United States
Chapel Hill, North Carolina 27514-4220, United States
Oklahoma City, Oklahoma 73120, United States
Nashville, Tennessee 37232-0028, United States
Houston, Texas 77030, United States
Wuhan, 430030, China
Zhengzhou, 450052, China
Paris, 75013, France
Strasbourg, 67098, France
München, 80336, Germany
Athens, 115 27, Greece
Milan, 20132, Italy
Roma, 00168, Italy
Torino, 10126, Italy
Matsudo-shi, 270-2251, Japan
Sagamihara-shi, 252-0375, Japan
Sasebo-shi, 857-1165, Japan
Ube-shi, 755-8505, Japan
Mexico City, 06700, Mexico
Amsterdam, 1105 AZ, Netherlands
Lima, 27, Peru
Szczecin, 71-252, Poland
Bangkok, 10300, Thailand
Bath, BA1 3NG, United Kingdom
Doncaster, DN2 5LT, United Kingdom
Leeds, LS7 4SA, United Kingdom
Liverpool, L9 7AL, United Kingdom
Middlesbrough, TS4 3BW, United Kingdom